Abstract 1508: Characterization of a novel clonal neoantigen reactive T cell (cNeT) product through a comprehensive translational research programMichael Epstein, Sergio A. Quezada, Megan Wileman et al.|Cancer Research|2021Cited by 2
Abstract CT054: The development of a personalized autologous clonal neoantigen T cell therapy for the treatment of solid cancer using the VELOSTM manufacturing platform generates highly potent and reactive CD8+ and CD4+ T cells for clinical useHenrieta Fraser, Edward Samuel, Rebecca Pike et al.|Cancer Research|2020Cited by 0